Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000475778 | SCV000543604 | uncertain significance | Hereditary nonpolyposis colon cancer | 2018-08-05 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with proline at codon 218 of the MLH1 protein (p.Ser218Pro). The serine residue is weakly conserved and there is a moderate physicochemical difference between serine and proline. This variant is present in population databases (rs750650349, ExAC 0.009%). This variant has not been reported in the literature in individuals with MLH1-related disease. ClinVar contains an entry for this variant (Variation ID: 405413). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV000564654 | SCV000662013 | uncertain significance | Hereditary cancer-predisposing syndrome | 2017-12-15 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: Insufficient or conflicting evidence |
Mendelics | RCV000708916 | SCV000838002 | uncertain significance | Lynch syndrome | 2018-07-02 | criteria provided, single submitter | clinical testing | |
Color | RCV000564654 | SCV000911477 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-10-18 | criteria provided, single submitter | clinical testing |